Search
COVID19 Clinical Trials in Riverside, CA
A listing of 2 COVID19 clinical trials in Riverside, CA actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
COVID19
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The city of Riverside, California, currently has 2 active clinical trials seeking participants for COVID19 research studies.
Featured Trial
COVID Vaccine (Age 50-64) Clinical Study
Recruiting
A clinical study for people that suffer with COVID Vaccine (Age 50-64)
Conditions:
COVID Vaccine (Age 50-64)
Featured Trial
COVID Vaccine Age 50-64 Study (Up to $710 Total Compensation)
Recruiting
Multiple COVID-19 investigational vaccine studies are now enrolling participants (Age 50-64), with appointments available. Participants who qualify may receive up to $710 in total compensation.
If eligible, participants may be matched to one of the current COVID-19 vaccine studies. Should you express interest, the study team will contact you directly to provide further details and answer any questions about study procedures, time commitment, potential risks/benefits, and compensation.
If eligible, participants may be matched to one of the current COVID-19 vaccine studies. Should you express interest, the study team will contact you directly to provide further details and answer any questions about study procedures, time commitment, potential risks/benefits, and compensation.
Conditions:
COVID Vaccine (Age 50-64)
COVID
COVID-19
COVID19
COVID 19
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Vaccine (18+) Clinical Study
Recruiting
We are seeking healthy individuals aged 18 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (18+)
Healthy
Healthy Individuals
Healthy Volunteers
Healthy Subjects
Featured Trial
Vaccine (65+) Clinical Study
Recruiting
We are seeking healthy participants aged 65 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (65+)
Healthy
Older Adults
Seniors
Healthy Volunteers
Featured Trial
Adult Vaccine Clinical Trial
Recruiting
Looking to boost your immunity?
You may be interested in participating in an Adult Vaccine Clinical Trial.
The Adult Vaccine Research Studies are looking for adults to evaluate the effectiveness of a potential vaccine.
You may be interested in participating in an Adult Vaccine Clinical Trial.
The Adult Vaccine Research Studies are looking for adults to evaluate the effectiveness of a potential vaccine.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Recruiting
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.
This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/18/2025
Locations: Artemis Institute for Clinical Research, Riverside, California
Conditions: Influenza, COVID-19 (Coronavirus Disease 2019)
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
Recruiting
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently approved COVID-19 vaccine in the prevention of symptomatic, RT-PCR-confirmed SARS-CoV-2 infection. The trial will enroll up to 10016 healthy participants.
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
05/14/2025
Locations: Artemis Institute for Clinical Research, Riverside, California +1 locations
Conditions: COVID-19
1 - 2 of 2